Global Human Growth Hormone Drugs Market Research Report 2018-2030F, by Region, Type, Application/End-Use
- Published Date: 2024-08-17
- Report ID: 161301
- Pages: 150
-
Format:
Summary
The global Human Growth Hormone Drugs market was estimated at xxx Million USD in 2021 and will reach xxx Million USD in 2030 with CAGR xx% during 2021-2030. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
The report includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels. The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Norditropin
Genotropin
Humatrope
Saizen
Omnitrope - the Somatropin Biosimilar
Somatropin Biopartners
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Eli Lilly and Company (US)
Ferring Holding SA (Switzerland)
Genentech, Inc. (US)
GeneScience Pharmaceuticals Co., Ltd. (China)
Merck KgaA (Germany)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (US)
Sandoz International GmbH (Germany)
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Prader-Willi Syndrome
Turner Syndrome
Short Stature Homeobox Gene
Small for Gestational Age
Chronic Renal Insufficiency
Short Bowel Syndrome
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Table of Contents
1 MARKET OVERVIEW
1.1 Human Growth Hormone Drugs of Research
1.1.1 Definition
1.1.2 Specifications of Human Growth Hormone Drugs
1.2 Market Segment by Product
1.2.1 Segment Overview
1.2.1.1 Norditropin Overview
1.2.1.2 Genotropin Overview
1.2.1.3 Humatrope Overview
1.2.1.4 Saizen Overview
1.2.1.5 Omnitrope - the Somatropin Biosimilar Overview
1.2.1.6 Somatropin Biopartners Overview
1.2.2 Segment Market Date
1.3 Market Segment by Application/End-Use
1.3.1 Segment Overview
1.3.1.1 Prader-Willi Syndrome
1.3.1.2 Turner Syndrome
1.3.1.3 Short Stature Homeobox Gene
1.3.1.4 Small for Gestational Age
1.3.1.5 Chronic Renal Insufficiency
1.3.1.6 Short Bowel Syndrome
1.3.2 Segment Market Date
1.4 Global & Major Region Market Size and Forecast
2 DEPLOYMENT ENVIRONMENT
2.1 Industry Chain Overview
2.1.1 Industry Chain
2.1.2 Manufacturing Process
2.2 Market Environment
2.2.1 SWOT
2.2.2 Dynamics
2.3 Marketing Channel
3 MARKET SEGMENTATION BY PRODUCT TYPE
3.1 Market Size by Product Type 2018-2023
3.1.1 Norditropin Market Size 2018-2023
3.1.1.1 Global Norditropin Market Size and Growth Rate 2018-2023
3.1.1.2 Global Norditropin Market Size by Region 2018-2023
3.1.2 Genotropin Market Size 2018-2023
3.1.2.1 Global Genotropin Market Size and Growth Rate 2018-2023
3.1.2.2 Global Genotropin Market Size by Region 2018-2023
3.1.3 Humatrope Market Size 2018-2023
3.1.3.1 Global Humatrope Market Size and Growth Rate 2018-2023
3.1.3.2 Global Humatrope Market Size by Region 2018-2023
3.1.4 Saizen Market Size 2018-2023
3.1.4.1 Global Saizen Market Size and Growth Rate 2018-2023
3.1.4.2 Global Saizen Market Size by Region 2018-2023
3.1.5 Omnitrope - the Somatropin Biosimilar Market Size 2018-2023
3.1.5.1 Global Omnitrope - the Somatropin Biosimilar Market Size and Growth Rate 2018-2023
3.1.5.2 Global Omnitrope - the Somatropin Biosimilar Market Size by Region 2018-2023
3.1.6 Somatropin Biopartners Market Size 2018-2023
3.1.6.1 Global Somatropin Biopartners Market Size and Growth Rate 2018-2023
3.1.6.2 Global Somatropin Biopartners Market Size by Region 2018-2023
3.2 Market Estimates and Forecasts by Product Type 2024E-2030F
3.2.1 Norditropin Market Estimates and Forecasts 2024E-2030F
3.2.1.1 Global Norditropin Market Forecasts and Growth Rate 2024E-2030F
3.2.1.2 Global Norditropin Market Estimates and Forecasts by Region 2024E-2030F
3.2.2 Genotropin Market Estimates and Forecasts 2024E-2030F
3.2.2.1 Global Genotropin Market Forecasts and Growth Rate 2024E-2030F
3.2.2.2 Global Genotropin Market Estimates and Forecasts by Region 2024E-2030F
3.2.3 Humatrope Market Estimates and Forecasts 2024E-2030F
3.2.3.1 Global Humatrope Market Forecasts and Growth Rate 2024E-2030F
3.2.3.2 Global Humatrope Market Estimates and Forecasts by Region 2024E-2030F
3.2.4 Saizen Market Estimates and Forecasts 2024E-2030F
3.2.4.1 Global Saizen Market Forecasts and Growth Rate 2024E-2030F
3.2.4.2 Global Saizen Market Estimates and Forecasts by Region 2024E-2030F
3.2.5 Omnitrope - the Somatropin Biosimilar Market Estimates and Forecasts 2024E-2030F
3.2.5.1 Global Omnitrope - the Somatropin Biosimilar Market Forecasts and Growth Rate 2024E-2030F
3.2.5.2 Global Omnitrope - the Somatropin Biosimilar Market Estimates and Forecasts by Region 2024E-2030F
3.2.6 Somatropin Biopartners Market Estimates and Forecasts 2024E-2030F
3.2.6.1 Global Somatropin Biopartners Market Forecasts and Growth Rate 2024E-2030F
3.2.6.2 Global Somatropin Biopartners Market Estimates and Forecasts by Region 2024E-2030F
4 MARKET SEGMENTATION BY APPLICATION/END-USE
4.1 Market Size by Application/End-Use 2018-2023
4.1.1 Prader-Willi Syndrome Market Size 2018-2023
4.1.1.1 Global Prader-Willi Syndrome Market Size and Growth Rate 2018-2023
4.1.1.2 Global Prader-Willi Syndrome Market Size by Region 2018-2023
4.1.2 Turner Syndrome Market Size 2018-2023
4.1.2.1 Global Turner Syndrome Market Size and Growth Rate 2018-2023
4.1.2.2 Global Turner Syndrome Market Size by Region 2018-2023
4.1.3 Short Stature Homeobox Gene Market Size 2018-2023
4.1.3.1 Global Short Stature Homeobox Gene Market Size and Growth Rate 2018-2023
4.1.3.2 Global Short Stature Homeobox Gene Market Size by Region 2018-2023
4.1.4 Small for Gestational Age Market Size 2018-2023
4.1.4.1 Global Small for Gestational Age Market Size and Growth Rate 2018-2023
4.1.4.2 Global Small for Gestational Age Market Size by Region 2018-2023
4.1.5 Chronic Renal Insufficiency Market Size 2018-2023
4.1.5.1 Global Chronic Renal Insufficiency Market Size and Growth Rate 2018-2023
4.1.5.2 Global Chronic Renal Insufficiency Market Size by Region 2018-2023
4.1.6 Short Bowel Syndrome Market Size 2018-2023
4.1.6.1 Global Short Bowel Syndrome Market Size and Growth Rate 2018-2023
4.1.6.2 Global Short Bowel Syndrome Market Size by Region 2018-2023
4.2 Market Estimates and Forecasts by Application/End-Use 2024E-2030F
4.2.1 Prader-Willi Syndrome Market Estimates and Forecasts 2024E-2030F
4.2.1.1 Global Prader-Willi Syndrome Market Forecasts and Growth Rate 2024E-2030F
4.2.1.2 Global Prader-Willi Syndrome Market Estimates and Forecasts by Region 2024E-2030F
4.2.2 Turner Syndrome Market Estimates and Forecasts 2024E-2030F
4.2.2.1 Global Turner Syndrome Market Forecasts and Growth Rate 2024E-2030F
4.2.2.2 Global Turner Syndrome Market Estimates and Forecasts by Region 2024E-2030F
4.2.3 Short Stature Homeobox Gene Market Estimates and Forecasts 2024E-2030F
4.2.3.1 Global Short Stature Homeobox Gene Market Forecasts and Growth Rate 2024E-2030F
4.2.3.2 Global Short Stature Homeobox Gene Market Estimates and Forecasts by Region 2024E-2030F
4.2.4 Small for Gestational Age Market Estimates and Forecasts 2024E-2030F
4.2.4.1 Global Small for Gestational Age Market Forecasts and Growth Rate 2024E-2030F
4.2.4.2 Global Small for Gestational Age Market Estimates and Forecasts by Region 2024E-2030F
4.2.5 Chronic Renal Insufficiency Market Estimates and Forecasts 2024E-2030F
4.2.5.1 Global Chronic Renal Insufficiency Market Forecasts and Growth Rate 2024E-2030F
4.2.5.2 Global Chronic Renal Insufficiency Market Estimates and Forecasts by Region 2024E-2030F
4.2.6 Short Bowel Syndrome Market Estimates and Forecasts 2024E-2030F
4.2.6.1 Global Short Bowel Syndrome Market Forecasts and Growth Rate 2024E-2030F
4.2.6.2 Global Short Bowel Syndrome Market Estimates and Forecasts by Region 2024E-2030F
5 MARKET SEGMENTATION BY DISTRIBUTION CHANNEL
5.1 Market Size by Distribution Channel 2018-2023
5.1. E-Commerce Market Size 2018-2023
5.1.1.1 Global E-Commerce Market Size and Growth Rate 2018-2023
5.1.1.2 Global E-Commerce Market Size by Region 2018-2023
5.1.2 Traditional Channel Market Size 2018-2023
5.1.2.1 Global Traditional Channel Market Size and Growth Rate 2018-2023
5.1.2.2 Global Traditional Channel Market Size by Region 2018-2023
5.2 Market Estimates and Forecasts by Distribution Channel 2024E-2030F
5.2.1 E-Commerce Market Estimates and Forecasts 2024E-2030F
5.2.1.1 Global E-Commerce Market Forecasts and Growth Rate 2024E-2030F
5.2.1.2 Global E-Commerce Market Estimates and Forecasts by Region 2024E-2030F
5.2.2 Traditional Channel Market Estimates and Forecasts 2024E-2030F
5.2.2.1 Global Traditional Channel Market Forecasts and Growth Rate 2024E-2030F
5.2.2.2 Global Traditional Channel Market Estimates and Forecasts by Region 2024E-2030F
6 MARKET SEGMENTATION by Country/COUNTRY
6.1 Market Size by Region 2018-2023
6.1.1 Asia-Pacific Market Size 2018-2023
6.1.1.1 Asia-Pacific Market Size and Growth Rate 2018-2023
6.1.1.2 Asia-Pacific Market Size by Country 2018-2023
6.1.1.3 Asia-Pacific Market Size by Product Type 2018-2023
6.1.1.4 Asia-Pacific Market Size by Application/End-Use 2018-2023
6.1.1.5 Asia-Pacific Market Size by Distribution Channel 2018-2023
6.1.2 Europe Market Size 2018-2023
6.1.2.1 Europe Market Size and Growth Rate 2018-2023
6.1.2.2 Europe Market Size by Country 2018-2023
6.1.2.3 Europe Market Size by Product Type 2018-2023
6.1.2.4 Europe Market Size by Application/End-Use 2018-2023
6.1.2.5 Europe Market Size by Distribution Channel 2018-2023
6.1.3 North America Market Size 2018-2023
6.1.3.1 North America Market Size and Growth Rate 2018-2023
6.1.3.2 North America Market Size by Country 2018-2023
6.1.3.3 North America Market Size by Product Type 2018-2023
6.1.3.4 North America Market Size by Application/End-Use 2018-2023
6.1.3.5 North America Market Size by Distribution Channel 2018-2023
6.1.4 South America Market Size 2018-2023
6.1.4.1 South America Market Size and Growth Rate 2018-2023
6.1.4.2 South America Market Size by Country 2018-2023
6.1.4.3 South America Market Size by Product Type 2018-2023
6.1.4.4 South America Market Size by Application/End-Use 2018-2023
6.1.4.5 South America Market Size by Distribution Channel 2018-2023
6.1.5 Middle East & Africa Market Size 2018-2023
6.1.5.1 Middle East & Africa Market Size and Growth Rate 2018-2023
6.1.5.2 Middle East & Africa Market Size by Country 2018-2023
6.1.5.3 Middle East & Africa Market Size by Product Type 2018-2023
6.1.5.4 Middle East & Africa Market Size by Application/End-Use 2018-2023
6.1.5.5 Middle East & Africa Market Size by Distribution Channel 2018-2023
6.2 Market Estimates and Forecasts by Region 2024E-2030F
6.2.1 Asia-Pacific Market Estimates and Forecasts 2024E-2030F
6.2.1.1 Asia-Pacific Market Forecast and Growth Rate 2024E-2030F
6.2.1.2 Asia-Pacific Market Estimates & Forecast by Country 2024E-2030F
6.2.1.3 Asia-Pacific Market Estimates & Forecast by Product Type 2024E-2030F
6.2.1.4 Asia-Pacific Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.1.5 Asia-Pacific Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.2 Europe Market Estimates and Forecasts 2024E-2030F
6.2.2.1 Europe Market Forecast and Growth Rate 2024E-2030F
6.2.2.2 Europe Market Estimates & Forecast by Country 2024E-2030F
6.2.2.3 Europe Market Estimates & Forecast by Product Type 2024E-2030F
6.2.2.4 Europe Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.2.5 Europe Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.3 North America Market Estimates and Forecasts 2024E-2030F
6.2.3.1 North America Market Forecast and Growth Rate 2024E-2030F
6.2.3.2 North America Market Estimates & Forecast by Country 2024E-2030F
6.2.3.3 North America Market Estimates & Forecast by Product Type 2024E-2030F
6.2.3.4 North America Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.3.5 North America Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.4 South America Market Estimates and Forecasts 2024E-2030F
6.2.4.1 South America Market Forecast and Growth Rate 2024E-2030F
6.2.4.2 South America Market Estimates & Forecast by Country 2024E-2030F
6.2.4.3 South America Market Estimates & Forecast by Product Type 2024E-2030F
6.2.4.4 South America Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.4.5 South America Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.5 Middle East & Africa Market Estimates and Forecasts 2024E-2030F
6.2.5.1 Middle East & Africa Market Forecast and Growth Rate 2024E-2030F
6.2.5.2 Middle East & Africa Market Estimates & Forecast by Country 2024E-2030F
6.2.5.3 Middle East & Africa Market Estimates & Forecast by Product Type 2024E-2030F
6.2.5.4 Middle East & Africa Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.5.5 Middle East & Africa Market Estimates & Forecast by Distribution Channel 2024E-2030F
7 MARKET COMPETITIVE
7.1 Global Human Growth Hormone Drugs Market Competition
7.1.1 Global Human Growth Hormone Drugs Market by Companies
7.1.2 Global Human Growth Hormone Drugs Market Share
7.2 Market Concentration
7.3 Mergers & Acquisition Overview
7.4 Price & Factors
7.4.1 Price Overview
7.4.2 Factors
8 MAJOR PLAYERS OVERVIEW
8.1 Eli Lilly and Company (US)
8.1.1 Eli Lilly and Company (US) Company Profile
8.1.2 Eli Lilly and Company (US) Product Portfolio
8.1.3 Eli Lilly and Company (US) Business Performance
8.1.4 Eli Lilly and Company (US) Development Overview
8.2 Ferring Holding SA (Switzerland)
8.2.1 Ferring Holding SA (Switzerland) Company Profile
8.2.2 Ferring Holding SA (Switzerland) Product Portfolio
8.2.3 Ferring Holding SA (Switzerland) Business Performance
8.2.4 Ferring Holding SA (Switzerland) Development Overview
8.3 Genentech, Inc. (US)
8.3.1 Genentech, Inc. (US) Company Profile
8.3.2 Genentech, Inc. (US) Product Portfolio
8.3.3 Genentech, Inc. (US) Business Performance
8.3.4 Genentech, Inc. (US) Development Overview
8.4 GeneScience Pharmaceuticals Co., Ltd. (China)
8.4.1 GeneScience Pharmaceuticals Co., Ltd. (China) Company Profile
8.4.2 GeneScience Pharmaceuticals Co., Ltd. (China) Product Portfolio
8.4.3 GeneScience Pharmaceuticals Co., Ltd. (China) Business Performance
8.4.4 GeneScience Pharmaceuticals Co., Ltd. (China) Development Overview
8.5 Merck KgaA (Germany)
8.5.1 Merck KgaA (Germany) Company Profile
8.5.2 Merck KgaA (Germany) Product Portfolio
8.5.3 Merck KgaA (Germany) Business Performance
8.5.4 Merck KgaA (Germany) Development Overview
8.6 Novo Nordisk A/S (Denmark)
8.6.1 Novo Nordisk A/S (Denmark) Company Profile
8.6.2 Novo Nordisk A/S (Denmark) Product Portfolio
8.6.3 Novo Nordisk A/S (Denmark) Business Performance
8.6.4 Novo Nordisk A/S (Denmark) Development Overview
8.7 Pfizer, Inc. (US)
8.7.1 Pfizer, Inc. (US) Company Profile
8.7.2 Pfizer, Inc. (US) Product Portfolio
8.7.3 Pfizer, Inc. (US) Business Performance
8.7.4 Pfizer, Inc. (US) Development Overview
8.8 Sandoz International GmbH (Germany)
8.8.1 Sandoz International GmbH (Germany) Company Profile
8.8.2 Sandoz International GmbH (Germany) Product Portfolio
8.8.3 Sandoz International GmbH (Germany) Business Performance
8.8.4 Sandoz International GmbH (Germany) Development Overview
9 MARKET LANDSCAPE
9.1 Five Forces Analysis
9.1.1 Threat of New Entrants
9.1.2 Bargaining Power of Buyers
9.1.3 Threat of Substitutes
9.1.4 Segment Rivalry
9.2 Market Factors
9.2.1 Drivers
9.2.2 Restrains
9.2.3 Opportunities
10 MARKET CONCLUSION
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
24 * 7 Access to Analyst :
Get your pre and post sales queries resolved by our Subject matter experts.
Customization :
We will assist you to customize the report to fit your research needs.
Assured Quality :
Our prime focus is to provide qualitative and accurate data.
Free sample report :
Feel free to order a sample report before purchase.
Security :
Your personal and confidential information is safe and secured.
